Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator

D W Denning; L Gilliland; A Hewlett; L. O. Hughes; C. D. L.  Reid

doi:10.1016/s0140-6736(86)92046-5

Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator

D W Denning, L Gilliland, A Hewlett, L. O. Hughes, C. D. L. Reid

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1401-2
Number of pages	2
Journal	Lancet (London, England)
Volume	328
Issue number	8520
DOIs	https://doi.org/10.1016/s0140-6736(86)92046-5
Publication status	Published - 13 Dec 1986

Keywords

Adult
Epoprostenol/therapeutic use
Gangrene/therapy
Humans
Male
Middle Aged
Sepsis/therapy
Streptococcal Infections/complications
Streptococcus pneumoniae
Tissue Plasminogen Activator/therapeutic use

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0140-6736(86)92046-5

Cite this

@article{a7d09758dbd8473fac5eced2b4080bc8,

title = "Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator",

keywords = "Adult, Epoprostenol/therapeutic use, Gangrene/therapy, Humans, Male, Middle Aged, Sepsis/therapy, Streptococcal Infections/complications, Streptococcus pneumoniae, Tissue Plasminogen Activator/therapeutic use",

author = "Denning, {D W} and L Gilliland and A Hewlett and Hughes, {L. O.} and Reid, {C. D. L.}",

year = "1986",

month = dec,

day = "13",

doi = "10.1016/s0140-6736(86)92046-5",

language = "English",

volume = "328",

pages = "1401--2",

journal = "Lancet (London, England)",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "8520",

}

TY - JOUR

T1 - Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator

AU - Denning, D W

AU - Gilliland, L

AU - Hewlett, A

AU - Hughes, L. O.

AU - Reid, C. D. L.

PY - 1986/12/13

Y1 - 1986/12/13

KW - Adult

KW - Epoprostenol/therapeutic use

KW - Gangrene/therapy

KW - Humans

KW - Male

KW - Middle Aged

KW - Sepsis/therapy

KW - Streptococcal Infections/complications

KW - Streptococcus pneumoniae

KW - Tissue Plasminogen Activator/therapeutic use

U2 - 10.1016/s0140-6736(86)92046-5

DO - 10.1016/s0140-6736(86)92046-5

M3 - Letter

C2 - 2878263

SN - 0140-6736

VL - 328

SP - 1401

EP - 1402

JO - Lancet (London, England)

JF - Lancet (London, England)

IS - 8520

ER -